Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey

Fatemeh Salem 1 , Soheila Hekmat 1 , * , Mohammad Reza Aghasadeghi 1 , Foozieh Javadi 1 , Hossein Gholami 2 and Ehsan Mostafavi 3
Authors Information
1 Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, IR Iran
2 Executive deputy of health reference laboratory, Tehran, IR Iran
3 Department of Epidemiology, Pasteur institute of Iran, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2013, 6 (6); e10221
  • Published Online: August 1, 2013
  • Article Type: Research Article
  • Received: January 10, 2013
  • Revised: May 16, 2013
  • Accepted: May 21, 2013
  • DOI: 10.5812/jjm.10221

To Cite: Salem F, Hekmat S, Aghasadeghi M R, Javadi F, Gholami H, et al. Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey, Jundishapur J Microbiol. 2013 ; 6(6):e10221. doi: 10.5812/jjm.10221.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Mackie CO, Buxton JA, Tadwalkar S, Patrick DM. Hepatitis B immunization strategies: timing is everything. CMAJ. 2009; 180(2): 196-202[DOI][PubMed]
  • 2. World Health Organization . Hepatitis B.
  • 3. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 4. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007; 7(1): 3-5
  • 5. Alavian SM. On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in iran. Int J Prev Med. 2012; 3(7): 437-9[PubMed]
  • 6. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005; 23(19): 2409-23[DOI][PubMed]
  • 7. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008; 82(11): 5657-63[DOI][PubMed]
  • 8. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 9. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000; 118(3): 554-9[PubMed]
  • 10. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76(3): 318-26[DOI][PubMed]
  • 11. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1): 19-22[PubMed]
  • 12. Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iranian J Public Health. 2006; 35(4)
  • 13. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2): 121-6[PubMed]
  • 14. Decker MD, Vaughn WK, Brodie JS, Hutcheson RH, Jr, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984; 150(3): 450-9[PubMed]
  • 15. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000; 321(7253): 78-82[PubMed]
  • 16. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J. 2006; 3: 12[DOI][PubMed]
  • 17. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol. 2006; 12(32): 5211-3[PubMed]
  • 18. Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol. 2004; 10(21): 3132-6[PubMed]
  • 19. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980; 16(2): 111-20[PubMed]
  • 20. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4): 406-25[PubMed]
  • 21. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004; 5(2): 150-63[PubMed]
  • 22. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791): 571-83[DOI][PubMed]
  • 23. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2(1): 50-57[PubMed]
  • 24. Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, et al. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med. 2012; 6(4): 292-6[DOI][PubMed]
  • 25. Kidd-Ljunggren K, Myhre E, Blackberg J. Clinical and serological variation between patients infected with different Hepatitis B virus genotypes. J Clin Microbiol. 2004; 42(12): 5837-41[DOI][PubMed]
  • 26. Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ. 2010; 88(1): 66-73[DOI][PubMed]
  • 27. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004; 47(6): 289-309[DOI][PubMed]
  • 28. Panessa C, Hill WD, Giles E, Yu A, Harvard S, Butt G, et al. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat. 2009; 16(1): 64-73[DOI][PubMed]
  • 29. Fisker N, Pedersen C, Lange M, Nguyen NT, Nguyen KT, Georgsen J, et al. Molecular epidemiology of hepatitis B virus infections in Denmark. J Clin Virol. 2004; 31(1): 46-52[DOI][PubMed]
  • 30. International centre for prison studies . World prison brief.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments